Erythropoietin (EPO) Global Market Market Size, Share Analysis, Industry Trends, 2032

The Erythropoietin (EPO) Global Market Report 2023 by The Business Research Company, provides erythropoietin (EPO) market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-yearforecast period – 2023-2032.

 

Learn More On The Erythropoietin (EPO) Market:

https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

According to The Business Research Company’s Erythropoietin (EPO) Global Market Report 2023, the market size grew from $13.94 billion in 2022 to $15.52 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the erythropoietin is expected to grow from $24.2 billion in 2027 at a CAGR of 11.7%.

The rising incidence of chronic kidney diseases is anticipated to propel the demand for the erythropoietin market over the coming years. The growing cases of chronic kidney disease require erythropoietin administration, which is used to make red blood cells to improve immunity.

 

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=3436&type=smp

The erythropoietin (EPO) market is segmented:

1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products
2) By Application: Cancer, Hematology, Renal diseases, Neurology, Other Applications
3) By Drug Class: Biologis, Biosimilar

The increasing prevalence of kidney diseases is expected to drive the erythropoietin market. Erythropoietin is used by people on dialysis and is used widely to treat anemia in patients with chronic kidney disease. For instance, according to the American Journal of Kidney Diseases, the number of US adults aged 30 or older who have chronic kidney disease (CKD) is projected to increase from 13.2% in 2015, to 16.7% in 2030, which represents a total increase of almost 27%.  According to an estimate by German healthcare company, Fresenius Medical Care, the number of people suffering from chronic kidney failure is expected to increase from 3.7 million patients in 2020 to 4.9 million by 2025.  Hence the growing incidence of kidney diseases is expected to drive the erythropoietin market.

The erythropoietin (EPO) market report table of contents includes:
1. Executive Summary
2. Erythropoietin (EPO) Market Characteristics
3. Erythropoietin (EPO) Market Trends And Strategies
4. Erythropoietin (EPO) Market – Macro Economic Scenario
5. COVID-19 Impact On Erythropoietin (EPO) Market
……………………………….
27. Erythropoietin (EPO) Market Competitive Landscape And Company Profiles
28. Erythropoietin (EPO) Pipeline Analysis
29. Key Mergers And Acquisitions In The Erythropoietin (EPO) Market
30. Erythropoietin (EPO) Market Future Outlook and Potential Analysis
31. Appendix

 

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn:https://in.linkedin.com/company/the-business-research-company

Twitter:https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog:https://blog.tbrc.info/

Healthcare Blog:https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model